Skip to main content
. 2011 May;71(5):758–765. doi: 10.1111/j.1365-2125.2010.03897.x

Table 2.

Annual incidences in Toulouse urban unit (A) and region (B) of serious cannabis-related adverse events among recent and regular cannabis users

A) Urban unit
Patients Incidence (·10−3)
Year n Recent users* (95% CI) Regular users (95% CI)
2004 25 0.67 (0.41, 0.94) 1.15 (0.70, 1.60)
2005 41 1.08 (0.75, 1.42) 1.86 (1.29, 2.43)
2006 61 1.59 (1.19, 1.99) 2.73 (2.04, 3.41)
2007 73 1.87 (1.44, 2.30) 3.20 (2.47, 3.94)
B) Region
Hypothesis 1: ‘Cannabis users who needed to be hospitalized in Midi-Pyrenees were all admitted to a Toulouse teaching hospital.’
Patients Incidence (·10−3)
Year n (95% CI) Recent users* (95% CI) Regular users (95% CI)
2004 25 (5, 45) 0.30 (0.18, 0.42) 0.52 (0.31, 0.72)
2005 41 (21, 61) 0.49 (0.34, 0.63) 0.83 (0.58, 1.09)
2006 61 (41, 81) 0.71 (0.53, 0.89) 1.22 (0.92, 1.53)
2007 73 (53, 93) 0.84 (0.65, 1.03) 1.44 (1.11, 1.77)
Hypothesis 2: ‘Annual incidence is constant and observations made at urban unit scale can be proportionally reported to Midi-Pyrenees region.’
Patients Incidence (·10−3)
Year n (95% CI) Recent users* (95% CI) Regular users (95% CI)
2004 56 (13, 99) 0.67 (0.41, 0.94) 1.15 (0.70, 1.60)
2005 91 (47, 135) 1.08 (0.75, 1.42) 1.86 (1.29, 2.43)
2006 136 (92, 181) 1.59 (1.19, 1.99) 2.73 (2.04, 3.41)
2007 162 (117, 207) 1.87 (1.44, 2.30) 3.20 (2.47, 3.94)
*

Recent use: Between one and nine uses during the last 30 days.

Regular use: 10 or more uses during the last 30 days.